Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 3 1

Status

Completed 11Unknown 3Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Conditions

Polycystic Ovary Syndrome 3

Interventions

Cisplatin 509Cyclophosphamide 360Carboplatin 352Radiotherapy 350Capecitabine 329Paclitaxel 325Oxaliplatin 324Gemcitabine 319Docetaxel 311Fluorouracil 283Drug Therapy 243apatinib 242Bevacizumab 229camrelizumab 214Etoposide 200Irinotecan 176Doxorubicin 175Leucovorin 161Dexamethasone 160sintilimab 142pembrolizumab 138anlotinib 136Pemetrexed 136Cytarabine 136toripalimab 129Neoadjuvant Therapy 122S 1 (combination) 120Vincristine 119Rituximab 117Radiosurgery 117

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Interventional × Contraceptives, Oral × Clear all
NCT03843736 2019-10-10

The Role of Dysbiosis of Gut Microbiota in the Pathogenesis of PCOS.

Peking Union Medical College Hospital

Phase 3 Unknown
200 enrolled

Polycystic Ovary Syndrome

NCT02744131 2018-02-05

OCP

Kar Clinic & Hospital Pvt. Ltd.

Phase NA Unknown
100 enrolled

Polycystic Ovary Syndrome

NCT01798875 2013-03-01

PCOS, Therapy and Markers of Cardiovascular Risk

Medical University of Gdansk

Phase 4 Unknown
50 enrolled

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡